CHARLOTTE, N.C., Feb. 2, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leading innovator in wellness and hemp-derived consumer products, today announced a major distribution expansion for its Herbal Oasis THC-infused social seltzer ("Oasis") through an expanded partnership with Morales Beverage Group ("MBG"). The agreement extends Oasis into Louisiana, strengthening the brand's regional footprint across the Gulf South and creating a more contiguous platform for continued Southeast growth, follow ...

"We are intentionally building a durable regulatory-grade foundation designed for the next era of federal regulation and scrutiny and opportunity," said Ronan Kennedy, CEO of cbdMD. "By integrating Bluebird's established GRAS work with cbdMD's clinical and toxicology platform—and advancing both through a highly cost-efficient internal regulatory science strategy—we believe cbdMD is well-positioned to engage credibly with regulators, the medical community, and healthcare innovation stakeholders as CMS and CM ...

As filed with the Securities and Exchange Commission on January 22, 2026 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 https://files.reportify.cc/media/production/YCBDb17d9984a353796dfdab814bdba02089.jpg cbdMD, Inc. (Exact Name of Registrant As Specified In Its Charter) | North Carolina | 2833 | 47-3414576 | | --- | --- | --- | | (State Or Other Jurisdiction Of Incorporation Or Organization) | (P ...

CHARLOTTE, N.C., Jan. 14, 2026 /PRNewswire/ -- cbdMD, Inc (NYSE American: YCBD), a leading innovator in hemp-derived wellness products, announced today the closing of the acquisition of substantially all of the assets of Bluebird Botanicals, one of the longest-standing brands in the CBD industry, providing an established and complementary revenue base to strengthen cbdMD's long-term growth strategy. The transaction was completed through an asset purchase comprised of an initial share issuance and earnout s ...

Core Viewpoint - cbdMD, Inc. (YCBD) is demonstrating steady growth and improving financial health through strategic initiatives and disciplined cost management [1][2][5] Financial Performance - YCBD reported revenue of approximately $4.72 million for the period, slightly above the estimated $4.70 million, indicating steady growth [2][5] - The company has significantly reduced its operating loss to $2.1 million, an improvement from the $3.3 million loss in fiscal 2024, attributed to disciplined cost management and investments in quality and science [2][5] Financial Position - YCBD has strengthened its financial position through a $2.25 million Series C Preferred Stock private placement, with approximately $2.1 million available for working capital and strategic initiatives after expenses [3] - The Series C shares offer a 10% annual dividend and conversion options, providing flexibility for investors [3] - The company maintains a low debt-to-equity ratio of 0.16, indicating modest debt levels, and a current ratio of 1.56, suggesting good liquidity to cover short-term liabilities [4]

As filed with the Securities and Exchange Commission on December 22, 2025 Registration No. 333-291362 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 cbdMD, Inc. (Exact Name of Registrant As Specified In Its Charter) | North Carolina | 2833 | 47-3414576 | | --- | --- | --- | | (State Or Other Jurisdiction Of Incorporation Or Organization) | (Primary Standard Industrial | (I.R.S. Employer ...

Company Updates - Greenlane Holdings Inc. announced the resignation of its CEO, Barbara Sher, effective immediately, leading to an 11% drop in shares, closing at $2.35 on Friday [1] - Tokyo Lifestyle Co. Ltd. reported a loss of 2 cents per share for H1, compared to earnings of 3 cents per share in the previous year, while sales increased to $190.421 million from $98.003 million, resulting in a 3.3% decline in shares to $2.66 in after-hours trading [1] - Comfort Systems USA Inc. appointed COO Trent T. McKenna as president, effective January 1, with shares gaining 0.6% to $945.99 in after-hours trading [1] - cbdMD Inc. reported a loss of 8 cents per share for the fourth quarter, slightly worse than market estimates of a loss of 7 cents per share, but sales of $4.721 million exceeded estimates of $4.702 million, leading to a 1.3% increase in shares to $1.53 in after-hours trading [1] - Rithm Property Trust Inc. announced a 1-for-6 reverse stock split effective December 30, 2025, with shares falling 2.5% to close at $2.78 on Friday [1]

Financial Data and Key Metrics Changes - For fiscal year 2025, the company reported total net sales of $19.1 million, a slight decrease from $19.5 million in the prior year [16][20] - The operating loss for fiscal 2025 was approximately $2.1 million, improved from a loss of $3.3 million in 2024 [6][23] - Adjusted non-GAAP EBITDA improved from a loss of $1.7 million in 2024 to a loss of $900,000 in 2025 [6][25] - Gross profit margin for the fourth quarter of fiscal 2025 was 59%, up from 54% in the prior year [21] Business Line Data and Key Metrics Changes - E-commerce direct-to-consumer sales for the fourth quarter of fiscal 2025 were $3.5 million, a 6% year-over-year decrease [16][17] - The wholesale business generated $1.2 million in net sales for the fourth quarter of fiscal 2025, a 25% increase compared to $900,000 in the same quarter of fiscal 2024 [19][20] - For fiscal year 2025, the wholesale business generated net sales of $4.5 million, up from $3.8 million in 2024 [20] Market Data and Key Metrics Changes - Distribution for the new beverage brand, Oasis, has expanded to nine states, with improving case sell-through and growing distributor engagement [7][8] - E-commerce represented 77% of total net sales for fiscal year 2025, down from 81% in the prior year [17] Company Strategy and Development Direction - The company is focused on scaling the Oasis brand responsibly while driving efficient, profitable direct-to-consumer growth [29] - The strategy includes preserving margins and capital discipline while evaluating strategic opportunities aligned with regulatory strength [29] - The company aims to capitalize on the evolving regulatory environment, particularly with the recent executive order from the White House [12][13] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's position in the evolving regulatory landscape, highlighting the potential for increased demand for CBD products [12][30] - The company believes that the heavy lifting of the turnaround is largely behind them, with fiscal 2026 focused on improving financial performance [30] - Management noted that the executive order could lead to significant demand for quality CBD products, particularly among Medicare consumers [46] Other Important Information - The company eliminated over $7 million in annual accrued preferred dividend obligations, significantly improving working capital [9][26] - The company has a strong liquidity position entering calendar 2026, with cash and cash equivalents of approximately $2.2 million [26][28] - The NYSE American confirmed that all prior compliance deficiencies had been resolved, reflecting progress in financial stability [11] Q&A Session Summary Question: What will be the key driver of growth in 2026? - Management believes there are growth opportunities in both the core cbdMD brand and the beverage side, with visibility on growth through November [35] Question: Can you explain the decline in direct-to-consumer business? - Management indicated that the decline is tied to organizational changes and is trending slightly up over prior year periods [36][37] Question: What is the timeline for Medicare coverage of CBD products? - Management mentioned that a pilot program is expected to start on April 1st, with potential for significant demand increase [39][40] Question: How will the executive order impact the business? - Management views the executive order as a potential game changer, with significant demand for CBD products expected in the coming years [45][46] Question: How are you prioritizing growth investments for fiscal 2026? - Management indicated that the next quarter will likely see more investment in the Oasis side, with ongoing evaluations based on regulatory developments [66]

Financial Data and Key Metrics Changes - For fiscal year 2025, the company reported total net sales of $19.1 million, a decrease from $19.5 million in the prior year, representing a 2% decline [16] - The operating loss for fiscal 2025 was approximately $2.1 million, improved from a loss of $3.3 million in 2024, marking the third consecutive year of reduced operating losses [6][23] - Adjusted non-GAAP EBITDA improved from a loss of $1.7 million in 2024 to a loss of $900,000 in 2025, driven by cost control and efficient marketing [6][25] - Gross profit margin for the fourth quarter of fiscal 2025 was 59%, up from 54% in the prior year, while the full fiscal year gross margin was 63% compared to 62% in 2024 [21] Business Line Data and Key Metrics Changes - E-commerce direct-to-consumer sales for the fourth quarter of fiscal 2025 were $3.5 million, a 6% decrease year-over-year, and represented 75.1% of total net sales for that quarter [16][17] - The wholesale business generated $1.2 million in net sales for the fourth quarter of fiscal 2025, a 25% increase from $900,000 in the same quarter of fiscal 2024 [19] - For the fiscal year, wholesale sales increased from $3.8 million in 2024 to $4.5 million in 2025 [20] Market Data and Key Metrics Changes - Distribution for the new beverage brand, Oasis, expanded to nine states, with improving case sell-through and growing distributor engagement [7] - The company is positioned in the functional alcohol alternative beverage segment, which is experiencing rapid growth due to changing consumer preferences [7] Company Strategy and Development Direction - The company is focused on scaling the Oasis brand responsibly while driving profitable growth through disciplined marketing execution [29] - A significant emphasis is placed on maintaining a strong balance sheet and capital discipline while evaluating strategic opportunities [29] - The company aims to capitalize on evolving regulatory environments and consumer demand for quality CBD products [14][30] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's improved financial position and the potential for significant demand growth due to recent regulatory changes [12][30] - The executive order from the White House is seen as a positive signal for the hemp and CBD industry, potentially leading to increased consumer access and reimbursement pathways [12][13] - The company believes it is well-positioned to benefit from regulatory clarity and is focused on maintaining compliance and quality [14] Other Important Information - The company successfully eliminated over $7 million in annual accrued preferred dividend obligations, significantly improving working capital [9][27] - As of September 30, 2025, the company had cash and cash equivalents of approximately $2.2 million and working capital of approximately $3.3 million, a significant improvement from the previous year [26][27] Q&A Session Summary Question: What will be the key driver of growth in 2026? - Management indicated that both the core cbdMD brand and the Oasis beverage brand have significant growth opportunities, with a focus on the beverage side due to market visibility [34][35] Question: Can you explain the decline in direct-to-consumer sales? - Management noted that the decline is partly due to SKU rationalization and organizational changes, but overall trends are showing slight improvement [36][37] Question: What is the timeline for Medicare coverage of CBD products? - Management mentioned that a pilot program is expected to start on April 1st, with potential for significant demand growth in the coming years [38][39] Question: How will the executive order impact the business? - Management believes the executive order could lead to a substantial increase in demand for CBD products, estimating a potential $30 billion market opportunity [44][46] Question: How will the company prioritize growth investments in 2026? - Management indicated that the focus for the next quarter will lean more towards the Oasis brand, with ongoing evaluations based on regulatory developments [65][66]

Financial Data and Key Metrics Changes - For fiscal year 2025, the company reduced its operating loss by $1.2 million to approximately $2.1 million, marking the third consecutive year of improved operating results [4] - Adjusted non-GAAP EBITDA improved from a $1.7 million loss in 2024 to a $900,000 loss in 2025, driven by disciplined cost control and efficient marketing spend [4][15] - Total net sales for fiscal year 2025 were $19.1 million, a slight decrease from $19.5 million in the prior year [10] - Gross profit as a percentage of net sales increased to 63% for fiscal 2025, compared to 62% in the previous year [12] Business Line Data and Key Metrics Changes - E-commerce direct-to-consumer sales for the fourth quarter of fiscal 2025 were $3.5 million, a 6% year-over-year decrease, representing 75.1% of total net sales for that quarter [10] - The wholesale business generated $1.2 million in net sales for the fourth quarter of fiscal 2025, up 25% from $900,000 in the same quarter of fiscal 2024 [11] - The company focused on SKU rationalization and prioritizing higher velocity products across its core brands, which helped stabilize the business while maintaining strong gross margins [5] Market Data and Key Metrics Changes - The company has distribution across nine states for its new beverage brand, Oasis, and is evaluating additional markets [4] - The executive order from the White House regarding federal cannabis policy is expected to positively impact the hemp and CBD industry, potentially increasing demand for quality products [8][30] Company Strategy and Development Direction - The company is focused on scaling the Oasis brand responsibly while driving efficient, profitable direct-to-consumer growth through disciplined marketing execution [17] - The management aims to preserve margins and capital discipline while evaluating strategic opportunities aligned with regulatory strength [17] - The company believes it is well-positioned to benefit from improving regulatory clarity and is committed to maintaining a strong, flexible balance sheet [9][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's direction, highlighting lower operating losses and restored exchange compliance as key achievements [3][17] - The potential for significant demand increase due to Medicare reimbursement pathways for CBD products was noted, with estimates suggesting a $30 billion market opportunity [17][30] - The management emphasized the importance of navigating regulatory changes carefully while continuing to build a profitable long-term organization [30][44] Other Important Information - The company received confirmation from the NYSE American that all prior compliance deficiencies had been resolved, reflecting progress in restoring financial stability [7] - The company closed $2.25 million in additional financing, enhancing its liquidity position [5][16] Q&A Session Summary Question: What will be the key driver of growth in 2026? - Management indicated that both the core cbdMD brand and the Oasis beverage line have significant growth opportunities, with a focus on regulatory developments [20][22] Question: What caused the decline in direct-to-consumer sales? - Management explained that the decline was tied to organizational changes and SKU reductions, but noted a slight upward trend in the D2C business over the past 24 months [23][24] Question: What is the timeline for Medicare coverage of CBD products? - Management mentioned that a pilot program is expected to start on April 1st, with potential for significant demand increase for quality products [25][30] Question: How will the executive order impact the business? - Management believes the executive order could lead to a substantial increase in demand for CBD products, although the details of implementation are still being assessed [29][30] Question: How will the company prioritize growth investments in 2026? - Management indicated that for the next quarter, investment will be more weighted towards the Oasis side, with ongoing evaluations based on regulatory developments [46][48] Question: What is the current share count and any new executive compensation plans? - Management provided the current share count and mentioned that a new employee compensation plan is subject to shareholder vote in the upcoming annual meeting [49][52]